Paramus, NJ, United States of America

Xinyan Huang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Xinyan Huang

Introduction

Xinyan Huang is a prominent inventor based in Paramus, NJ (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of therapeutic agents. With a total of two patents to her name, her work focuses on innovative compounds that target specific disease mechanisms.

Latest Patents

Xinyan Huang's latest patents include "Fused bicyclic heterocycles as therapeutic agents" and "Inhibitors of GLI1 as therapeutic agents." The first patent relates to compounds and pharmaceutical compositions that are used for treating diseases associated with nicotinamide phosphoribosyltransferase (NAMPT) expression. This disclosure emphasizes the importance of fused bicyclic heterocyclic compounds in inhibiting NAMPT and treating related diseases. The second patent focuses on compounds that inhibit glioma-associated oncogene (Gli) expression, providing methods for treating diseases linked to Gli expression through the use of bicyclic compounds.

Career Highlights

Xinyan Huang is affiliated with New York University, where she continues her research and development in the pharmaceutical field. Her innovative work has positioned her as a key figure in the exploration of new therapeutic agents.

Collaborations

Some of her notable coworkers include Nadim Shohdy and William J Greenlee, who contribute to her research endeavors and collaborative projects.

Conclusion

Xinyan Huang's contributions to the field of pharmaceutical sciences through her innovative patents highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic solutions in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…